Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash flows from operating activities:
Net income including noncontrolling interest	$ 99.2	$ 23.4
Adjustments to reconcile net income including noncontrolling interest to net cash provided by operating activities:
Depreciation and amortization	59.0	64.1
Provision for bad debt	7.6	6.3
Valuation allowance against the net U.S. deferred tax assets	0.0	76.9
Share-based payment award compensation costs	8.0	15.3
Deferred income tax benefit	(1.8)	(21.2)
Foreign currency losses, net	4.9	8.4
Other	(0.8)	(2.4)
Changes in assets and liabilities, net of acquisitions:
Accounts receivable, net (reduced by beneficial interests received in exchange for accounts receivables sold of $109.3 million and $82.1 million for the three months ended September 30, 2018 and 2017, respectively, and $353.0 million and $239.2 million for the nine months ended September 30, 2018 and 2017, respectively.)	(775.5)	(492.6)
Inventories	(177.1)	(69.5)
Prepaid expenses	(17.2)	(9.8)
Short-term derivative assets, net	(35.7)	28.4
Other current assets	(36.9)	(49.7)
Cash collateral with financial counterparties	40.0	(15.6)
Other non-current assets	(39.3)	(19.3)
Accounts payable	554.0	253.7
Customer deposits	(1.1)	6.4
Accrued expenses and other current liabilities	(6.4)	0.0
Non-current income tax, net and other long-term liabilities	3.2	5.9
Total adjustments	(415.2)	(214.5)
Net cash used in operating activities	(316.0)	(191.1)
Cash flows from investing activities:
Cash receipts of retained beneficial interests in receivable sales	357.5	236.3
Acquisition of businesses, net of cash acquired	(21.0)	(94.6)
Capital expenditures	(44.7)	(37.8)
Other investing activities, net	7.3	(0.5)
Net cash provided by investing activities	299.0	103.4
Cash flows from financing activities:
Borrowings of debt	4,663.5	3,500.1
Repayments of debt	(4,841.2)	(3,492.6)
Dividends paid on common stock	(12.1)	(12.3)
Purchases of common stock tendered by employees to satisfy the required withholding taxes related to share-based payment awards	(2.2)	(4.0)
Purchases of common stock	(20.0)	(61.9)
Other financing activities, net	0.0	(2.0)
Net cash used in financing activities	(212.0)	(72.7)
Effect of exchange rate changes on cash and cash equivalents	(1.3)	7.8
Net decrease in cash and cash equivalents	(230.3)	(152.6)
Cash and cash equivalents, as of beginning of period	372.3	698.6
Cash and cash equivalents, as of end of period	$ 142.1	$ 546.0